Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Arrhythmia Research Technology, Inc. Declares Cash Dividend.


FITCHBURG, Mass. -- Arrhythmia Research Technology, Inc. (the "Company") (AMEX AMEX

See: American Stock Exchange
: HRT HRT
abbr.
hormone replacement therapy


Hormone replacement therapy (HRT)
Also called estrogen replacement therapy, this controversial treatment is used to relieve the discomforts of menopause.
) announced that its Board of Directors approved the payment of a dividend of $0.06 per share to holders of record on September 13, 2005, payable on September 23, 2005. Future dividend declarations by the Board of Directors will depend upon a number of factors, including future operating results, and other investment and acquisition opportunities.

James E. Rouse, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , stated "The Board of Directors of the Company declared a $0.06 cash dividend will be paid to our shareholders as a result of the earnings achieved in the first six months of 2005."

About the Company:

In addition to its proprietary SAECG SAECG Signal-Averaged Electrocardiogram  software used in the detection of potentially lethal heart arrhythmias the Company, through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
, Micron Products Inc., manufacturers silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG ECG electrocardiogram.

ECG
abbr.
1. electrocardiogram

2. electrocardiograph


ECG
Also called an electrocardiogram, it records the electrical activity of the heart.
, EEG EEG: see electroencephalography. , EMS, and TENS electrodes. Micron's New England Molders division manufactures custom injection molded products for medical, electronic, industrial and consumer applications.

Forward-looking statements made herein are based on current expectations of the Company that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include: interruptions or cancellation of existing contracts, impact of competitive products and pricing, product demand and market acceptance, risks, the presence of competitors with greater financial resources than the Company, product development and commercialization risks, and changing economic conditions in developing countries. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2004.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 29, 2005
Words:296
Previous Article:ScanSource Named Microsoft Retail Distributor of the Year.
Next Article:Servigistics Pricing Solution Delivers Significant Results at Leading Automotive OEMs; Report from Leading Analyst Firm Highlights Revenue and...
Topics:



Related Articles
ART Names New President.
Arrhythmia Research Technology, Inc. Makes Announcement.
Arrhythmia Research Technology, Inc. Declares Its First Cash Dividend.
Arrhythmia Research Technology, Inc. Declares Cash Dividend.
Arrhythmia Research Technology, Inc. Announces Promotion.
Arrhythmia Research Technology, Inc. Declares Cash Dividend.
Arrhythmia Research Technology, Inc. Announces Results of Annual Meeting.
Arrhythmia Research Technology, Inc. Announces 3-Year Agreement with IDEXX Laboratories.
Arrhythmia Research Technology, Inc. Declares Cash Dividend.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles